Spots Global Cancer Trial Database for Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Official Title: A Phase III, Multicenter, Randomized, Parallel-group Study to Assess the Efficacy and Safety of Double-blind Pasireotide LAR 40 mg and Pasireotide LAR 60 mg Versus Open-label Octreotide LAR or Lanreotide ATG in Patients With Inadequately Controlled Acromegaly
Study ID: NCT01137682
Conditions
Study Description
Brief Summary: This study will evaluate the efficacy and safety of pasireotide LAR 40 and 60 mg versus octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Michigan, Ann Arbor, Michigan, United States
Oregon Health & Science University, Portland, Oregon, United States
University of Texas Southwestern Medical Center Division of Hematology/Oncolog, Dallas, Texas, United States
Swedish Neuroscience Institute 550 17th Avenue, Suite 500, Seattle, Washington, United States
Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, Edegem, Antwerpen, Belgium
Novartis Investigative Site, Brussels, , Belgium
Novartis Investigative Site, Gent, , Belgium
Novartis Investigative Site, Leuven, , Belgium
Novartis Investigative Site, Fortaleza, CE, Brazil
Novartis Investigative Site, Sao Luis, MA, Brazil
Novartis Investigative Site, Rio de Janeiro, RJ, Brazil
Novartis Investigative Site, Joinville, SC, Brazil
Novartis Investigative Site, Botucatu, SP, Brazil
Novartis Investigative Site, Campinas, SP, Brazil
Novartis Investigative Site, Sao Paulo, SP, Brazil
Novartis Investigative Site, São Paulo, SP, Brazil
Novartis Investigative Site, Sherbrooke, Quebec, Canada
Novartis Investigative Site, Bogota, Cundinamarca, Colombia
Novartis Investigative Site, Bogotá, , Colombia
Novartis Investigative Site, Cali, , Colombia
Novartis Investigative Site, Toulouse, Cedex 9, France
Novartis Investigative Site, Bron, Cedex, France
Novartis Investigative Site, Dijon, , France
Novartis Investigative Site, Le Kremlin Bicetre, , France
Novartis Investigative Site, Lille, , France
Novartis Investigative Site, Marseille, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Pessac Cedex, , France
Novartis Investigative Site, Rennes Cedex, , France
Novartis Investigative Site, Saint Herblain - Nantes, , France
Novartis Investigative Site, Erlangen, , Germany
Novartis Investigative Site, Hamburg, , Germany
Novartis Investigative Site, Muenchen, , Germany
Novartis Investigative Site, Wurzburg, , Germany
Novartis Investigative Site, Petach Tikva, , Israel
Novartis Investigative Site, Genova, GE, Italy
Novartis Investigative Site, Messina, ME, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Torino, TO, Italy
Novartis Investigative Site, Napoli, , Italy
Novartis Investigative Site, Bergen, , Norway
Novartis Investigative Site, Oslo, , Norway
Novartis Investigative Site, Gdansk, , Poland
Novartis Investigative Site, Poznan, , Poland
Novartis Investigative Site, Wroclaw, , Poland
Novartis Investigative Site, Bucuresti, , Romania
Novartis Investigative Site, Barnaul, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Tyumen, , Russian Federation
Novartis Investigative Site, Jeddah, , Saudi Arabia
Novartis Investigative Site, Riyadh, , Saudi Arabia
Novartis Investigative Site, Sevilla, Andalucia, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Alicante, Comunidad Valenciana, Spain
Novartis Investigative Site, Altunizade, , Turkey
Novartis Investigative Site, Antalya, , Turkey
Novartis Investigative Site, Izmir, , Turkey
Novartis Investigative Site, Plymouth, , United Kingdom
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
